Inhibitors of the mitotic kinesin spindle protein

By Coleman Paul J   Fraley Mark E  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 12, 2004-12 ,pp. : 1659-1667

Informa Healthcare

Access to resources Recommend Favorite

Kinesin spindle protein Inhibitors as anticancer agents

By Jiang Cheng   You Qidong   Li Zhiyu   Guo Qinglong  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 11, 2006-11 ,pp. : 1517-1532

Informa Healthcare

Access to resources Recommend Favorite

Developments of Kinesin Spindle Protein Inhibitors as Antitumor Agents Based on the Five-membered Heterocycle Scaffolds

By  

Current Medicinal Chemistry, Vol. 21, Iss. 23, 2014-01 ,pp. : 2691-2701

Bentham Science Publishers

Access to resources Recommend Favorite

Kinesin spindle protein inhibitors in cancer: a patent review (2008 – present)

By Jiang Cheng   You Qidong  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 12, 2013-12 ,pp. : 1547-1560

Informa Healthcare

Access to resources Recommend Favorite

A phase I study of ispinesib, a kinesin spindle protein inhibitor, administered weekly for three consecutive weeks of a 28-day cycle in patients with solid tumors

By Burris Howard   Jones Suzanne   Williams Daphne   Kathman Steven   Hodge Jeffrey   Pandite Lini   Ho Peter   Boerner Scott   LoRusso Patricia  

Investigational New Drugs, Vol. 29, Iss. 3, 2011-06 ,pp. : 467-472

Springer Publishing Company

Access to resources Recommend Favorite